Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Clemons

Showing results (101-110 of 267) with videos related to

Pageof 27
Sort By:
Journal of Bone Oncology|February 25, 2016
De-escalated administration of bone-targeted agents in patients with breast and prostate cancer-A survey of Canadian oncologistsBrian Hutton, Christina Addison, Sasha Mazzarello, et al.
Medical Physics|September 21, 2007
Quantitative characterization of metastatic disease in the spine. Part II. Histogram-based analysesCarl Whyne, Michael Hardisty, Florence Wu, et al.
Clinical Breast Cancer|May 13, 2009
Prevalence and severity of urogenital symptoms in postmenopausal women receiving endocrine therapy for breast cancerSheray N Chin, Mateya Trinkaus, Christine Simmons, et al.
Current Oncology (Toronto, Ont.)|April 3, 2021
Neoadjuvant Chemotherapy in Breast Cancer: Review of the Evidence and Conditions That Facilitated Its Use during the Global PandemicTabitha Tse, Sandeep Sehdev, Jean Seely, et al.
Breast Cancer Research and Treatment|April 2, 2005
Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and deathEileen Rakovitch, Jean-Philippe Pignol, Carole Chartier, et al.
American Journal of Clinical Oncology|June 7, 2007
Survival differences observed in metastatic breast cancer patients treated with capecitabine when compared with vinorelbine after pretreatment with anthracycline and taxaneSunil Verma, Nan Soon Wong, Maureen Trudeau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2006
Pegylated liposomal doxorubicin and trastuzumab in HER-2 overexpressing metastatic breast cancer: a multicenter phase II trialStephen Chia, Mark Clemons, Lee-Ann Martin, et al.
Journal of Pain and Symptom Management|April 15, 2009
Switching breast cancer patients with progressive bone metastases to third-generation bisphosphonates: measuring impact using the Functional Assessment of Cancer Therapy-Bone PainReuben Broom, Hongyan Du, Mark Clemons, et al.
Anticancer Research|July 15, 2009
Altered calcium metabolism in patients on long-term bisphosphonate therapy for metastatic breast cancerChristine Simmons, Eitan Amir, George Dranitsaris, et al.
Springerplus|May 3, 2014
Patient perceptions and expectations regarding imaging for metastatic disease in early stage breast cancerDemetrios Simos, Brian Hutton, Ian D Graham, et al.
Pageof 27

Showing results (101-110 of 267) with videos related to

Sort By:
Pageof 27
Journal of Bone Oncology|February 25, 2016
De-escalated administration of bone-targeted agents in patients with breast and prostate cancer-A survey of Canadian oncologistsBrian Hutton, Christina Addison, Sasha Mazzarello, et al.
Medical Physics|September 21, 2007
Quantitative characterization of metastatic disease in the spine. Part II. Histogram-based analysesCarl Whyne, Michael Hardisty, Florence Wu, et al.
Clinical Breast Cancer|May 13, 2009
Prevalence and severity of urogenital symptoms in postmenopausal women receiving endocrine therapy for breast cancerSheray N Chin, Mateya Trinkaus, Christine Simmons, et al.
Current Oncology (Toronto, Ont.)|April 3, 2021
Neoadjuvant Chemotherapy in Breast Cancer: Review of the Evidence and Conditions That Facilitated Its Use during the Global PandemicTabitha Tse, Sandeep Sehdev, Jean Seely, et al.
Breast Cancer Research and Treatment|April 2, 2005
Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and deathEileen Rakovitch, Jean-Philippe Pignol, Carole Chartier, et al.
American Journal of Clinical Oncology|June 7, 2007
Survival differences observed in metastatic breast cancer patients treated with capecitabine when compared with vinorelbine after pretreatment with anthracycline and taxaneSunil Verma, Nan Soon Wong, Maureen Trudeau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2006
Pegylated liposomal doxorubicin and trastuzumab in HER-2 overexpressing metastatic breast cancer: a multicenter phase II trialStephen Chia, Mark Clemons, Lee-Ann Martin, et al.
Journal of Pain and Symptom Management|April 15, 2009
Switching breast cancer patients with progressive bone metastases to third-generation bisphosphonates: measuring impact using the Functional Assessment of Cancer Therapy-Bone PainReuben Broom, Hongyan Du, Mark Clemons, et al.
Anticancer Research|July 15, 2009
Altered calcium metabolism in patients on long-term bisphosphonate therapy for metastatic breast cancerChristine Simmons, Eitan Amir, George Dranitsaris, et al.
Springerplus|May 3, 2014
Patient perceptions and expectations regarding imaging for metastatic disease in early stage breast cancerDemetrios Simos, Brian Hutton, Ian D Graham, et al.
Pageof 27